Table 2.
1. Assess lung function at baseline |
2. Administer 400 mcg Salbutamol through a spacer |
3. Re-assess lung function after 15 minutes |
4. An increase in FEV1 and/or in FVC ≥12% and ≥200 mL constitutes a positive bronchodilator response |
1. Assess lung function at baseline |
2. Administer 400 mcg Salbutamol through a spacer |
3. Re-assess lung function after 15 minutes |
4. An increase in FEV1 and/or in FVC ≥12% and ≥200 mL constitutes a positive bronchodilator response |